Biblio

Export 555 results:
Author [ Keyword(Desc)] Title Type Year
Filters: Keyword is Humans  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Humans
A. Bryndis Einarsdottir, Hardarson, S. Hakon, Kristjansdottir, J. Valgerdur, Bragason, D. Thor, Snaedal, J., and Stefánsson, E., Retinal oximetry imaging in Alzheimer's disease., J Alzheimers Dis, vol. 49, no. 1, pp. 79-83, 2016.
B. Yoon, Shim, Y. S., Park, H. - K., Park, S. Ah, Choi, S. Hye, and Yang, D. Won, Predictive factors for disease progression in patients with early-onset Alzheimer's disease., J Alzheimers Dis, vol. 49, no. 1, pp. 85-91, 2016.
S. Agostini, Mancuso, R., Baglio, F., Cabinio, M., Hernis, A., Guerini, F. Rosa, Calabrese, E., Nemni, R., and Clerici, M., Lack of evidence for a role of HHV-6 in the pathogenesis of Alzheimer's disease., J Alzheimers Dis, vol. 49, no. 1, pp. 229-35, 2016.
N. Kandiah, Wang, V., Lin, X., Nyu, M. Mei, Lim, L., Ng, A., Hameed, S., and Wee, H. Lin, Cost Related to Dementia in the Young and the Impact of Etiological Subtype on Cost., J Alzheimers Dis, vol. 49, no. 2, pp. 277-85, 2016.
A. Nørgaard, Jensen-Dahm, C., Gasse, C., Hansen, H. Vibe, and Waldemar, G., Time trends in antipsychotic drug use in patients with dementia: a nationwide study., J Alzheimers Dis, vol. 49, no. 1, pp. 211-20, 2016.
X. Sun, Ma, R., Yao, X., Shang, X., Wang, Q., Wang, J. - Z., and Liu, G., Concanavalin agglutinin levels are decreased in peripheral blood of Alzheimer's disease patients., J Alzheimers Dis, vol. 49, no. 1, pp. 63-72, 2016.
S. V. Ovsepian and O'Leary, V. B., Neuronal activity and amyloid plaque pathology: an update., J Alzheimers Dis, vol. 49, no. 1, pp. 13-9, 2016.
P. Pastor, Moreno, F., Clarimón, J., Ruiz, A., Combarros, O., Calero, M., de Munain, A. López, Bullido, M. J., de Pancorbo, M. M., Carro, E., Antonell, A., Coto, E., Ortega-Cubero, S., Hernandez, I., Tárraga, L., Boada, M., Lleo, A., Dols-Icardo, O., Kulisevsky, J., Vázquez-Higuera, J. Luis, Infante, J., Rábano, A., Fernández-Blázquez, M. Ángel, Valentí, M., Indakoetxea, B., Barandiarán, M., Gorostidi, A., Frank-García, A., Sastre, I., Lorenzo, E., Pastor, M. A., Elcoroaristizabal, X., Lennarz, M., Maier, W., Rámirez, A., Serrano-Ríos, M., Lee, S. E., and Sánchez-Juan, P., MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium., J Alzheimers Dis, vol. 49, no. 2, pp. 343-52, 2016.
D. Bensamoun, Guignard, R., Furst, A. J., Derreumaux, A., Manera, V., Darcourt, J., Benoit, M., Robert, P. H., and David, R., Associations between Neuropsychiatric Symptoms and Cerebral Amyloid Deposition in Cognitively Impaired Elderly People., J Alzheimers Dis, vol. 49, no. 2, pp. 387-98, 2016.
G. Berge, Lauridsen, C., Sando, S. Botne, Holder, D. Joseph, Møller, I., Aasly, J. Olav, Bråthen, G., Savage, M. Josephine, and White, L. Rosemary, Effect of Tween-20 on Core Biomarkers Measured in Cerebrospinal Fluid from Patients with Alzheimer's Disease, Mild Cognitive Impairment, or Healthy Control Individuals., J Alzheimers Dis, vol. 49, no. 2, pp. 493-502, 2016.
A. Jacquin-Piques, Sacco, G., Tavassoli, N., Rouaud, O., Bejot, Y., Giroud, M., Robert, P., Vellas, B., and Bonin-Guillaume, S., Psychotropic Drug Prescription in Patients with Dementia: Nursing Home Residents Versus Patients Living at Home., J Alzheimers Dis, vol. 49, no. 3, pp. 671-80, 2016.
D. Bergeron, Beauregard, J. - M., Guimond, J., Fortin, M. - P., Houde, M., Poulin, S., Verret, L., Bouchard, R. W., and Laforce, R., Clinical Impact of a Second FDG-PET in Atypical/Unclear Dementia Syndromes., J Alzheimers Dis, vol. 49, no. 3, pp. 695-705, 2016.
P. Joussain, Bessy, M., Fournel, A., Ferdenzi, C., Rouby, C., Delphin-Combe, F., Krolak-Salmon, P., and Bensafi, M., Altered Affective Evaluations of Smells in Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 2, pp. 433-41, 2016.
T. Minh Do, Dodacki, A., Alata, W., Calon, F., Nicolic, S., Scherrmann, J. - M., Farinotti, R., and Bourasset, F., Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD)., J Alzheimers Dis, vol. 49, no. 2, pp. 287-300, 2016.
Z. Rusznák, Kim, W. Scott, Hsiao, J. - H. T., Halliday, G. M., Paxinos, G., and Fu, Y. H., Early in vivo Effects of the Human Mutant Amyloid-β Protein Precursor (hAβPPSwInd) on the Mouse Olfactory Bulb., J Alzheimers Dis, vol. 49, no. 2, pp. 443-57, 2016.
M. Raizes, Elkana, O., Franko, M., Springer, R. Ravona, Segev, S., and Beeri, M. Schnaider, Higher Fasting Plasma Glucose Levels, within the Normal Range, are Associated with Decreased Processing Speed in High Functioning Young Elderly., J Alzheimers Dis, vol. 49, no. 3, pp. 589-92, 2016.
Z. Shi, Zhu, Y., Wang, M., Wu, Y., Cao, J., Li, C., Xie, Z., and Shen, Y., The Utilization of Retinal Nerve Fiber Layer Thickness to Predict Cognitive Deterioration., J Alzheimers Dis, vol. 49, no. 2, pp. 399-405, 2016.
A. Johnen, Frommeyer, J., Modes, F., Wiendl, H., Duning, T., and Lohmann, H., Dementia Apraxia Test (DATE): A Brief Tool to Differentiate Behavioral Variant Frontotemporal Dementia from Alzheimer's Dementia Based on Apraxia Profiles., J Alzheimers Dis, vol. 49, no. 3, pp. 593-605, 2016.
Y. Pan, Liu, R., Terpstra, E., Wang, Y., Qiao, F., Wang, J., Tong, Y., and Pan, B., Dysregulation and diagnostic potential of microRNA in Alzheimer's disease., J Alzheimers Dis, vol. 49, no. 1, pp. 1-12, 2016.
K. Miwa, Tanaka, M., Okazaki, S., Yagita, Y., Sakaguchi, M., Mochizuki, H., and Kitagawa, K., Increased Total Homocysteine Levels Predict the Risk of Incident Dementia Independent of Cerebral Small-Vessel Diseases and Vascular Risk Factors., J Alzheimers Dis, vol. 49, no. 2, pp. 503-13, 2016.
E. C. Pinnock, Jovanovic, K., Pinto, M. G., Ferreira, E., Dias, B. Da Costa, Penny, C., Knackmuss, S., Reusch, U., Little, M., Schatzl, H. M., and Weiss, S. F. T., LRP/LR Antibody Mediated Rescuing of Amyloid-β-Induced Cytotoxicity is Dependent on PrPc in Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 3, pp. 645-57, 2016.
Y. Yoo, Shin, S. A., Park, S., Lee, J. - H., Youn, J. - H., Kim, Y. Kyeong, and Lee, J. - Y., The Korean Size/Weight Attribute Test: A Semantic Knowledge Test for Korean Older Adults and Brain-Imaging Evidence., J Alzheimers Dis, vol. 49, no. 2, pp. 377-86, 2016.
D. Chu, Tan, J., Xie, S., Jin, N., Yin, X., Gong, C. - X., Iqbal, K., and Liu, F., GSK-3β is Dephosphorylated by PP2A in a Leu309 Methylation-Independent Manner., J Alzheimers Dis, vol. 49, no. 2, pp. 365-75, 2016.
D. Jigar Shah, Rohlfing, F., Anand, S., W Johnson, E., Alvarez, M. H. Tanielle B., Cobell, J., King, J., Young, S. A., Kauwe, J. S. K., and Graves, S. W., Discovery and Subsequent Confirmation of Novel Serum Biomarkers Diagnosing Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 2, pp. 317-27, 2016.
A. Madhavan, Schwarz, C. G., Duffy, J. R., Strand, E. A., Machulda, M. M., Drubach, D. A., Kantarci, K., Przybelski, S. A., Reid, R. I., Senjem, M. L., Gunter, J. L., Apostolova, L. G., Lowe, V. J., Petersen, R. C., Jack, C. R., Josephs, K. A., and Whitwell, J. L., Characterizing White Matter Tract Degeneration in Syndromic Variants of Alzheimer's Disease: A Diffusion Tensor Imaging Study., J Alzheimers Dis, vol. 49, no. 3, pp. 633-43, 2016.

Pages